Vimarsana
Biggest News Aggregation in the World

Page 33 - Initially Neutral News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initially Neutral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initially Neutral Today - Breaking & Trending Today

RENAULT SA : Gets a Neutral rating from Goldman Sachs -November 17, 2023 at 04:19 am EST - Vimarsana News

RENAULT SA : Gets a Neutral rating from Goldman Sachs -November 17, 2023 at 04:19 am EST

Initially Neutral on the company, Goldman Sachs's analyst George Galliers maintained his recommendation. The target price has been revised downwards and is now set at EUR 48 as compared to EUR 51...

ADIDAS : Goldman Sachs gives a Neutral rating -November 17, 2023 at 03:13 am EST - Vimarsana News

ADIDAS : Goldman Sachs gives a Neutral rating -November 17, 2023 at 03:13 am EST

Initially Neutral on the company, Goldman Sachs's analyst Richard Edwards maintained his recommendation. Previously set at EUR 220, the target price has been slightly modified to EUR 215.

GSK : Jefferies reiterates its Neutral rating -November 16, 2023 at 11:02 am EST - Vimarsana News

GSK : Jefferies reiterates its Neutral rating -November 16, 2023 at 11:02 am EST

Initially Neutral on the company, Jefferies's analyst Peter Welford maintained his recommendation. The target price is unchanged at GBX 1650.

QIAGEN NV : Jefferies reiterates its Neutral rating -November 15, 2023 at 11:50 am EST - Vimarsana News

QIAGEN NV : Jefferies reiterates its Neutral rating -November 15, 2023 at 11:50 am EST

Initially Neutral on the company, Jefferies's analyst Peter Welford maintained his recommendation. The target price remains unchanged at EUR 42.

SALZGITTER AG : JP Morgan sticks Neutral -November 13, 2023 at 02:59 pm EST - Vimarsana News

SALZGITTER AG : JP Morgan sticks Neutral -November 13, 2023 at 02:59 pm EST

Initially Neutral on the company, JP Morgan's analyst Moses Ola maintained his recommendation. Previously set at EUR 28.20, the target price has been slightly modified to EUR 28.40.